Available for licensing and analytics, these datasets enable faster access to research-grade IBD condition data, including longitudinal outcomes

BOSTON, Sept. 14, 2022 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, today announced the launch of its PremiOM™ Ulcerative Colitis (UC) and Crohn’s Disease (CD) datasets, providing comprehensive, clinically-deep and representative data to support a broad assortment of research needs.

Read the full press release.